Press Release

Global Transplant Diagnostics Market to Grow at a CAGR of 14.8% During 2024-2032, Driven by Increasing Prevalence of Chronic Diseases

Global Transplant Diagnostics Market

According to a new report by EMR titled, ‘Global Transplant Diagnostics Market Report and Forecast 2024-2032’, the market attained a value of about USD 3.7 billion in 2023. The market is estimated to grow at a CAGR of 14.8% in the forecast period of 2024-2032 to reach a value of around USD 6.8 billion by 2032.

The rising prevalence of chronic diseases, such as diabetes, cardiovascular diseases, and kidney diseases, which can lead to organ failure, is estimated to bolster the transplant diagnostics market size in the forecast period. The global increase in these health conditions drives the need for effective diagnostic solutions to facilitate successful transplantation outcomes.


The world is experiencing a significant increase in the elderly population, who are more susceptible to conditions requiring organ transplants. This demographic shift increases the demand for transplant diagnostics to support the growing number of transplantation procedures among the elderly. The market report covers multiple factors driving market growth. It analyses opportunities and challenges impacting the market, while providing insights to the competitive landscape for market leaders.


Mergers and acquisitions amongst healthcare industry pioneers is a major transplant diagnostics market trend. Increasing public awareness about organ donation and transplantation, driven by educational campaigns and non-profit organizations, has led to a higher willingness among individuals to donate organs. This cultural shift positively impacts the number of organ transplants performed and, by extension, the demand for transplant diagnostics.


In April 2023, CareDx, Inc., and Miromatrix Medical Inc. unveiled an exclusive collaboration designed to propel the next frontier of innovation with fully transplantable bioengineered human organs. Under this partnership, CareDx is set to create a cutting-edge testing solution specifically for Miromatrix's use in pre-clinical animal studies. Moreover, CareDx will become the sole provider of donor-derived cell-free DNA (dd-cfDNA) testing services. These services will play a crucial role in the non-invasive monitoring of acute allograft rejection during human clinical trials of Miromatrix’s bioengineered human organ products.


Innovations in molecular diagnostics, such as next-generation sequencing (NGS) and polymerase chain reaction (PCR) technologies, have dramatically improved the accuracy, speed, and affordability of transplant diagnostics. These advancements enable more precise matching of donors and recipients, reduce the risk of transplant rejection, and increase the overall success rates of transplantation procedures.


Stringent regulatory policies regarding organ transplantation and diagnostic procedures ensure the safety, efficacy, and quality of transplant diagnostics. Furthermore, government initiatives and funding in healthcare infrastructure and research significantly contribute to the development and adoption of advanced diagnostic technologies.


The globalization of healthcare services, including the cross-border exchange of medical services and collaboration in research and development, has facilitated the spread of advanced diagnostic technologies across countries. This trend enables broader access to transplant diagnostic solutions, thereby increasing their demand globally.


The level of healthcare expenditure and the extent of insurance coverage for transplant procedures and associated diagnostics can significantly influence market demand. Regions with higher healthcare spending and comprehensive insurance policies that cover transplant diagnostics tend to exhibit stronger demand.


Read more about this report REQUEST FREE SAMPLE COPY IN PDF


Market Analysis by Product and Services, Technology, Applications, Transplant types, End Users and Region

  • The market, based on product and services, can be divided into reagents and consumables, instruments, software, and services.
  • Based on technology, the transplant diagnostics market segmentation includes molecular assay technologies, sequencing based molecular assays, and non-molecular assays.
  • The various applications of transplant diagnostics include diagnostic applications and research applications.
  • On the basis of transplant type, solid organ transplantation, stem cell transplantation, soft tissue transplantation and bone marrow transplantation are included in the market report.
  • Reference laboratories, hospital and transplant centers, research laboratories and academic institutes, among others are key end users of the market.
  • Geographically, the global transplant diagnostics market report covers several major markets such as North America, Europe, Asia Pacific, Latin America along with Middle East and Africa.


Key Findings of the Report

  • The report identifies a significant shift towards the adoption of NGS technologies within the transplant diagnostics field. NGS offers unparalleled depth and breadth in genetic analysis, enabling more accurate donor-recipient matching and a better understanding of transplant rejection risks. This trend underscores the industry's move towards more personalized and precise transplantation medicine, reflecting broader healthcare shifts towards personalized care.
  • Emerging markets, particularly in the Asia Pacific region, are experiencing a surge in demand for transplant diagnostic services. This growth is driven by increasing healthcare expenditures, growing awareness about organ transplantation, and improvements in healthcare infrastructure. The expanding patient base in these regions presents a substantial opportunity for market expansion but also requires navigating diverse regulatory landscapes and healthcare practices.
  • The transplant diagnostics market analysis highlights the growing integration of artificial intelligence (AI) and machine learning (ML) in transplant diagnostics. These technologies are being leveraged to analyze complex datasets, improve the accuracy of diagnostic tests, and predict transplant outcomes more effectively. The adoption of AI and ML underscores the market's direction towards more data-driven and predictive approaches to transplantation diagnostics.
  • One of the key challenges identified in the report is the vulnerability of the supply chain for reagents and consumables. The COVID-19 pandemic has exposed significant supply chain weaknesses, affecting the availability of essential diagnostic materials. This issue underscores the need for robust supply chain strategies and the diversification of suppliers to ensure the continuity and reliability of transplant diagnostic services.
  • As transplant diagnostics become more advanced, regulatory and ethical considerations are becoming increasingly central to market dynamics. The report points out that stakeholders are facing complex regulatory environments, particularly concerning genetic data privacy and the ethical implications of organ matching algorithms. Navigating these regulatory landscapes is crucial for market participants to ensure compliance and maintain public trust.


Key Offerings of the Report 

  • The EMR report gives an overview of the global transplant diagnostics market for the periods (2017-2023) and (2024-2032).
  • The report also offers the historical (2017-2023) and forecast (2024-2032) market insights for  product and service types, technology types, transplant types, applications, end users and regions.
  • The report analyses the market dynamics, covering the key demand and price indicators in the market, along with an assessment of the SWOT and Porter’s Five Forces models.


The major players in the global transplant diagnostics market are Bio-Rad Laboratories Inc., Abbott Laboratories, Becton, Dickinson and Company, Biomérieux SA, CareDx, F Hoffman-La Roche AG, Hologic Inc., Illumina Inc., Qiagen NV, Thermo Fisher Scientific Inc., Immucor, Inc., Omixon Ltd., GenDx, and BioGenuix among others. The comprehensive report by EMR investigates the market share, capacity, and latest developments like mergers and acquisitions, plant turnarounds, and capacity expansions of the major players.


Key Highlights of the Report

Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Unit USD Billion
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Product and Services
  • Technology
  • Application
  • Transplant Type
  • End User
  • Region
Product and Services Covered 
  • Reagent and Consumables
  • Instruments
  • Software and Services
Technology Covered 
  • Molecular Assay
  • Non-molecular Assay
Application Covered 
  • Diagnostics Applications
  • Research Applications
Transplant Type Covered
  • Solid Organ Transplantation
  • Stem Cell Transplantation 
  • Soft Tissue Transplantation
  • Bone Marrow Transplantation
End User Covered
  • Reference Laboratories
  • Hospital and Transplant Centers
  • Research Laboratories and Academic Institutes
  • Other
Regions Covered 
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Countries Covered
  • United States of America,
  • Canada
  • Germany
  • France
  • United Kingdom,
  • Italy
  • China
  • Japan
  • India
  • Australia
  • Brazil
  • Argentina
  • Mexico
  • Saudi Arabia
  • United Arab Emirates
  • Nigeria
  • South Africa
Companies Covered
  • Bio-Rad Laboratories Inc. 
  • Abbott Laboratories
  • Becton, Dickinson and Company
  • Biomérieux SA
  • CareDx
  • F Hoffman-La Roche AG
  • Hologic Inc.
  • Illumina Inc.
  • Qiagen NV
  • Thermo Fisher Scientific Inc.
  • Immucor, Inc.
  • Omixon Ltd.
  • GenDx
  • BioGenuix
Customization Scope  10% Free Customization
Customization Scope 
  • Mini Report License: US$ 2999
  • Single User License: US$ 5499
  • Five User License: US$ 7499
  • Corporate License: US$ 9499 
Report Price and Purchase Option  10-12 Weeks
Delivery Format  PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)


About Us:

Expert Market Research (EMR) is a leading market research and business intelligence company, ensuring its clients remain at the vanguard of their industries by providing them with exhaustive and actionable market data through its syndicated and custom market reports, covering over 15 major industry domains. The company's expansive and ever-growing database of reports, which are constantly updated, includes reports from industry verticals like chemicals and materials, food and beverages, energy and mining, technology and media, consumer goods, pharmaceuticals, agriculture, and packaging.


EMR leverages its state-of-the-art technological and analytical tools, along with the expertise of its highly skilled team of over a 100 analysts and more than 3000 consultants, to help its clients, ranging from Fortune 1000 companies to small and medium sized enterprises, easily grasp the expansive industry data and help them in formulating market and business strategies, which ensure that they remain ahead of the curve.


Contact Us:

Expert Market Research
US & Canada Phone no: +1-415-325-5166
UK Phone no: +44-702-402-5790


*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.

Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.